Miltenyi Biomedicine Revenue and Competitors
Estimated Revenue & Valuation
- Miltenyi Biomedicine's estimated annual revenue is currently $36.8M per year.
- Miltenyi Biomedicine's estimated revenue per employee is $201,000
Employee Data
- Miltenyi Biomedicine has 183 Employees.
- Miltenyi Biomedicine grew their employee count by 19% last year.
Miltenyi Biomedicine's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Commercial Strategy and Organization | Reveal Email/Phone |
2 | Head Global Business Strategy, Analytics & Forecasting | Reveal Email/Phone |
3 | Associate Director Clinical Operations | Reveal Email/Phone |
4 | Associate Director, Regulatory CMC Cell Therapy | Reveal Email/Phone |
5 | Senior Director, Head Biostatistics, North America | Reveal Email/Phone |
6 | Global Director Supply Chain and PMO @ Miltenyi Biomedicine | Reveal Email/Phone |
7 | Director Global Clinical Operations | Reveal Email/Phone |
8 | Senior Medical Director | Reveal Email/Phone |
9 | Senior Manager Director Clinical Operations | Reveal Email/Phone |
10 | Senior Director Global Clinical Research & Development | Reveal Email/Phone |
Miltenyi Biomedicine Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $256.3M | 1275 | 24% | N/A | N/A |
#2 | $20.7M | 103 | 58% | N/A | N/A |
#3 | $36.8M | 183 | 19% | N/A | N/A |
#4 | $524.8M | 2611 | 69% | N/A | N/A |
#5 | $55.7M | 277 | 37% | N/A | N/A |
#6 | $231.2M | 1150 | 26% | N/A | N/A |
#7 | $130M | 647 | 85% | N/A | N/A |
#8 | $48.2M | 240 | 3% | N/A | N/A |
#9 | $177.5M | 883 | 5% | $17.8M | N/A |
#10 | $76.8M | 382 | 13% | N/A | N/A |
What Is Miltenyi Biomedicine?
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.
keywords:N/A
N/A
Total Funding
183
Number of Employees
$36.8M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Bergisch Gladbach
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $66.1M | 185 | 20% | N/A |